Medicare Enrolled

Dr. Matthew Retzloff, M.D.

Obstetrics & Gynecology · San Antonio, TX
Speaking/Promotional
7707 EWING HALSELL, SUITE 103, San Antonio, TX 78229
2106920577
In practice since 2005 (20 years)
NPI: 1659362218 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Retzloff from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Retzloff? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Retzloff

Dr. Matthew Retzloff is an obstetrics & gynecology specialist in San Antonio, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Retzloff received a total of $129,399 from 18 pharmaceutical and/or device companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Retzloff is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $129,399 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$129,399
Total received (2018-2024)
Avg $18,486/year across 7 years
Top 1% in TX for obstetrics & gynecology
18
Companies
355
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$119,809 (92.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,827 (6.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,764 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,628
2023
$11,248
2022
$21,833
2021
$13,003
2020
$26,651
2019
$23,215
2018
$14,821

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Organon LLC
$29,114
Olympus America Inc.
$26,115
Olympus Corporation of the Americas
$25,954
Merck Sharp & Dohme Corporation
$20,069
Organon Llc
$17,520
Medtronic, Inc.
$6,882
Duchesnay USA Incorporated
$1,201
Ferring Pharmaceuticals Inc.
$749
Olympus Winter & Ibe GmbH
$600
Acessa Health Inc.
$312
AbbVie, Inc.
$301
EMD Serono, Inc.
$295
Myovant Sciences Inc.
$114
Exeltis, USA Inc.
$68
AbbVie Inc.
$41
Hologic, LLC
$31
Galen US Inc
$18
CooperSurgical, Inc.
$14
Top 3 companies account for 62.7% of total payments
Associated products mentioned in payments ›
ACESSA PROVU SYSTEM · Acessa · Bonjesta · Dornier Medilas H Solvo · ENDOMETRIN · FOLLISTIM AQ · Fluid Management Capital · GANIRELIX · Gonal-f · HysteroBalance II · HysteroFlow II · INVOCELL · Lupron · MENOPUR · MYFEMBREE · NEXPLANON · Nexplanon · ORIAHNN · ORILISSA · Olympus · Olympus Cysto-Resection · Olympus Hysteroscopes Devices · Olympus Resection Disposables · Orilissa · Osphena · SLYND · STRIPPER · SYNERA · TRUCLEAR · ThunderBeat · TruClear · Vitafol Ultra
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in obstetrics & gynecology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for obstetrics & gynecology in TX.

Looking for an obstetrics & gynecology specialist in San Antonio?
Compare obstetricians & gynecologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists within 10 mi
307
Per 100K population
15.1
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Retzloff is an obstetrics & gynecology specialist, with speaking/promotional industry engagement in the top 1% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Retzloff receive payments from pharmaceutical companies?
Yes. Dr. Retzloff received a total of $129,399 from 18 companies across 355 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Retzloff) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →